PCI Pharma Services ("PCI" or the "Company"), a world-leading global contract development and manufacturing organization ...

The CDMO, which has been owned by different private investors over the last decade, will use the funds to broaden its ...

PCI Pharma Services has received a strategic investment co-led by Bain Capital and existing lead investor Kohlberg, and ...

(Alliance News) - Partners Group Private Equity Ltd on Tuesday said its investment manager, Partners Group Holding AG, has agreed to exit its existing stake in PCI Pharma Services and reinvest as a ...

Mubadala’s investment is part of a strategic transaction co-led by Bain Capital and existing lead investor Kohlberg ...

PCI Pharma Services, a Philadelphia-based biotherapy-focused contract development and manufacturing organization, has secured an investment co-led by Bain Capital and existing backer Kohlberg.

The firms lead an investment valuing PCI Pharma at $10 billion, see the company benefiting from broader trends.

A Philadelphia-based pharmaceutical services company has just received a massive investment from two major private equity firms, reportedly catapulting its valuation to $10 billion.

Following its minority investment in the new transaction, Partners Group will support the ownership group and management team in executing a value creation plan to further expand PCI's competitive ...

Part of $1 Billion Investment Strategy, PCI Pharma Services Completes Acquisition of Ajinomoto Althea, Enhancing US Drug Product Manufacturing for Aseptic Filling of Prefilled Syringes & Cartridges.

PHILADELPHIA, PA — PCI Pharma Services has finalized the acquisition of Ajinomoto Althea, Inc. (Althea), a U.S.-based sterile fill-finish contract development and manufacturing organization ...

Mubadala Investment Company, the Abu Dhabi-based sovereign wealth fund managing a global portfolio, is making a significant reinvestment in PCI Pharma Services (PCI).